RxDoctor Payments Data

Laura van Houten, MD

Obstetrics & Gynecology · Portland, ORNPI 1194937110

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $130 and has fallen 69.0% since, to $40 in 2024.

$278in general payments, 2019–2025

Across 17 payments — averaging $16.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$51
  • AbbVie$42
  • Bayer$40
  • Hologic Sales And Service, LLC$40
  • Intuitive Surgical$26
  • Astellas Pharma US Inc$21
  • plus $58 from 4 others

What the payments were for

  • Food & beverage$278100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$278 in reported general payments places this provider in the 55th percentile of 480 obstetrics & gynecology providers in Oregon.

See all obstetrics & gynecology providers in Oregon →

Medicare billing

Part B allowed, 2024
$5,988
Medicare patients
30
Services billed
107

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EstringEstradiol12$6,251
Estradiol55$2,949
ProgesteroneProgesterone, Micronized25$970

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Portland

See the full list for Oregon →

Where these figures come from

Is this you, or does something look wrong? →